Magnetic Resonance Spectroscopy Clinical Trials

6 recruiting

Magnetic Resonance Spectroscopy Trials at a Glance

7 actively recruiting trials for magnetic resonance spectroscopy are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Poitiers, Amiens, and Bern. Lead sponsors running magnetic resonance spectroscopy studies include Poitiers University Hospital, AdventHealth Translational Research Institute, and Centre Hospitalier Universitaire, Amiens.

Browse magnetic resonance spectroscopy trials by phase

About Magnetic Resonance Spectroscopy Clinical Trials

Looking for clinical trials for Magnetic Resonance Spectroscopy? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Magnetic Resonance Spectroscopy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Magnetic Resonance Spectroscopy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Non-Invasive Monitoring Of Metabolite Levels Using Novel And Adapted MR Spectroscopy Techniques

Magnetic Resonance Spectroscopy
Insel Gruppe AG, University Hospital Bern100 enrolled1 locationNCT05165537
Recruiting
Not Applicable

ETASCAN Project: ETAS Project 2

MRISleepCognition+3 more
University of Reading60 enrolled1 locationNCT07550140
Recruiting
Not Applicable

Effects of tDCS for Enhancing Cognitive Function in Individuals With Persistent Post-Concussion Syndrome

Transcranial Direct Current StimulationFunctional Magnetic Resonance ImagingMagnetic Resonance Spectroscopy+1 more
The Hong Kong Polytechnic University40 enrolled1 locationNCT06376500
Recruiting

Magnetic Resonance & Optical Spectroscopy Validation

Magnetic Resonance SpectroscopyValidation Studies
AdventHealth Translational Research Institute150 enrolled1 locationNCT01827527
Recruiting
Not Applicable

New Imaging Biomarkers Predictive of MA Progression

Alzheimer DiseaseMagnetic Resonance SpectroscopyUltra High Field 7T+2 more
Poitiers University Hospital80 enrolled1 locationNCT05939362
Recruiting
Not Applicable

Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the Tongue

Squamous Cell CarcinomaTranscriptomicsProton Magnetic Resonance Spectroscopy+1 more
Centre Hospitalier Universitaire, Amiens60 enrolled1 locationNCT06450080
Recruiting
Not Applicable

MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis

Multiple SclerosisMagnetic Resonance Spectroscopy
Poitiers University Hospital250 enrolled1 locationNCT05491031